CDMO collaboration propels cell replacement therapy targeting Duchenne muscular dystrophy forward, with consequences for the role of AI in cell therapy "I am excited about the long-term potential of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback